Michael  Doak net worth and biography

Michael Doak Biography and Net Worth

Director of Trupanion
Michael Doak is Chief Executive Officer, Managing Partner and Co-Chairman of Griffin Highline. Prior to founding Griffin Highline, Mr. Doak served in various leadership roles at entities associated with RenaissanceRe, a global provider of reinsurance and insurance services, since June 2010, most recently as President of RenaissanceRe Ventures U.S. LLC and the portfolio manager of the direct investments equity portfolio. Alongside other senior executives, he executed all of the RenaissanceRe acquisitions and divestitures, including the $1.9Bn Platinum Re and $1.5Bn Tokio Millenium Re acquisitions. In addition, Mr. Doak was a senior member of the team that managed in excess of $10Bn of ILS / alternative reinsurance capital.

Mr. Doak is a Director and Chairman of the Nominating and Governance Committee of Trupanion, Inc. (NSDQ: TRUP) and a Director of Langhorne Holdings, a global life reinsurer targeting large in-force life and annuity portfolios. He was previously a Director of Tower Hill Insurance Group, a Director of The Woodlands Financial Group and a Director of DaVinci Reinsurance Ltd.

Prior to RenaissanceRe, Mr. Doak was an investment banker in the Financial Institutions Group at Morgan Stanley & Co. LLC, where, among other transactions, he represented the United States Federal Reserve and Treasury in the $180Bn rehabilitation of AIG and SAFECO in its $6.2Bn sale to Liberty Mutual. He received a BA from the University of Virginia and a JD from the University of Pennsylvania Law School.

What is Michael Doak's net worth?

The estimated net worth of Michael Doak is at least $162,546.86 as of August 30th, 2023. Mr. Doak owns 5,866 shares of Trupanion stock worth more than $162,547 as of June 21st. This net worth evaluation does not reflect any other assets that Mr. Doak may own. Learn More about Michael Doak's net worth.

How do I contact Michael Doak?

The corporate mailing address for Mr. Doak and other Trupanion executives is 6100 4TH AVENUE SOUTH SUITE 200, SEATTLE WA, 98108. Trupanion can also be reached via phone at (855) 727-9079 and via email at [email protected]. Learn More on Michael Doak's contact information.

Has Michael Doak been buying or selling shares of Trupanion?

Michael Doak has not been actively trading shares of Trupanion during the last quarter. Most recently, Michael Doak sold 8,688 shares of the business's stock in a transaction on Wednesday, August 30th. The shares were sold at an average price of $29.99, for a transaction totalling $260,553.12. Following the completion of the sale, the director now directly owns 5,866 shares of the company's stock, valued at $175,921.34. Learn More on Michael Doak's trading history.

Who are Trupanion's active insiders?

Trupanion's insider roster includes Asher Bearman (Insider), Michael Doak (Director), Robin Ferracone (Director), Gavin Friedman (EVP), Dan Levitan (Director), Murray Low (Director), Tricia Plouf (CFO), Darryl Rawlings (CEO), Howard Rubin (Director), and Margaret Tooth (Insider). Learn More on Trupanion's active insiders.

Are insiders buying or selling shares of Trupanion?

During the last year, Trupanion insiders bought shares 1 times. They purchased a total of 20,700 shares worth more than $499,698.00. During the last year, insiders at the financial services provider sold shares 6 times. They sold a total of 25,396 shares worth more than $702,542.83. The most recent insider tranaction occured on May, 30th when EVP Steve Weinrauch sold 1,000 shares worth more than $29,350.00. Insiders at Trupanion own 5.5% of the company. Learn More about insider trades at Trupanion.

Information on this page was last updated on 5/30/2024.

Michael Doak Insider Trading History at Trupanion

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/30/2023Sell8,688$29.99$260,553.125,866View SEC Filing Icon  
3/28/2023Sell2,750$40.00$110,000.001,682View SEC Filing Icon  
1/5/2023Sell700$46.00$32,200.001,682View SEC Filing Icon  
10/5/2022Sell700$60.50$42,350.001,344View SEC Filing Icon  
7/5/2022Sell700$60.00$42,000.001,007View SEC Filing Icon  
4/5/2022Sell700$97.26$68,082.00View SEC Filing Icon  
3/29/2022Sell450$95.00$42,750.00View SEC Filing Icon  
3/24/2022Sell700$90.35$63,245.00View SEC Filing Icon  
8/30/2021Sell2,500$94.91$237,275.00View SEC Filing Icon  
11/18/2020Sell790$96.00$75,840.007,358View SEC Filing Icon  
See Full Table

Michael Doak Buying and Selling Activity at Trupanion

This chart shows Michael Doak's buying and selling at Trupanion by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Trupanion Company Overview

Trupanion logo
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. Trupanion, Inc. was founded in 2000 and is headquartered in Seattle, Washington.
Read More

Today's Range

Now: $27.71
Low: $26.89
High: $28.15

50 Day Range

MA: $26.49
Low: $19.85
High: $32.82

2 Week Range

Now: $27.71
Low: $18.45
High: $36.66


524,719 shs

Average Volume

721,853 shs

Market Capitalization

$1.16 billion

P/E Ratio


Dividend Yield